Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

REGENXBIO Inc. (RGNX)

46.23   -0.57 (-1.22%) 02-20 16:00
Open: 47.18 Pre. Close: 46.8
High: 47.5 Low: 45.65
Volume: 424,481 Market Cap: 1657M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 47.52 - 47.84 47.84 - 48.105
Low: 45.047 - 45.354 45.354 - 45.608
Close: 45.778 - 46.279 46.279 - 46.694

Technical analysis

as of: 2019-02-20 4:46:39 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 59.02     One year: 68.93
Support: Support1: 44.17    Support2: 40.24
Resistance: Resistance1: 50.53    Resistance2: 59.02
Pivot: 45.62
Moving Average: MA(5): 46.60     MA(20): 44.85
MA(100): 54.44     MA(250): 54.44
MACD: MACD(12,26): 0.32     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 63.45     %D(3): 64.11
RSI: RSI(14): 51.61
52-week: High: 85.10  Low: 26.75  Change(%): 70.6
Average Vol(K): 3-Month: 49292  10-Days: 39385

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
RGNX has closed below upper band by 39.5%. Bollinger Bands are 58.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to RGNX's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-02-20T07:00:00-05:00
REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35.84
Shares Float (M) 35.46
% Held by Insiders
% Held by Institutions 124.40
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 2.080
EPS Est. Current Year -2.930
EPS Est. Next Year -2.950
EPS Est. Next Quarter -0.770
Forward EPS -3.229
Book Value (p.s.) 3.420
PEG Ratio 10.47
Profit Margin 53.81
Operating Margin 38.41
Return on Assets (ttm) 22.1
Return on Equity (ttm) 23.2
Qtrly Rev. Growth 297.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 94.96
Levered Free Cash Flow (M) 48.06

Stock Valuations

P/E 22.23
P/E Growth Ratio -0.01
P/BV 13.52
P/S 296932480.00
P/CF 17.45

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.